# Expert Review of Hematology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/expert-review-of-hematology/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1747-4086 |
| ISSNs | 1747-4086,1747-4094 |
| OpenAlex ID | https://openalex.org/S73682863 |
| Publisher | Taylor & Francis |

## Journal papers

- [Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd](https://scholariq.org/papers/real-world-outcomes-and-factors-impacting-treatment-choice-in-relapsed-and-or/)
- [Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors](https://scholariq.org/papers/novel-approaches-to-the-treatment-of-sickle-cell-disease-the-potential-of/)
- [Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from <i>grupo argentino de mieloma múltiple</i>](https://scholariq.org/papers/real-world-outcomes-for-the-treatment-of-relapsed-refractory-multiple-myeloma/)
- [MiR-106b-5p, MiR-200c-3p, and MiR-146a-5p expression as putative biomarkers for disease state in primary immune thrombocytopenia](https://scholariq.org/papers/mir-106b-5p-mir-200c-3p-and-mir-146a-5p-expression-as-putative-biomarkers-for/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.